Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report)’s stock price was up 1.8% on Wednesday . The stock traded as high as $0.52 and last traded at $0.52. Approximately 7,700 shares were traded during trading, a decline of 44% from the average daily volume of 13,844 shares. The stock had previously closed at $0.52.
Spectral Medical Price Performance
The company has a market cap of $149.46 million, a price-to-earnings ratio of -7.50 and a beta of 0.84. The business’s 50-day simple moving average is $0.44 and its 200-day simple moving average is $0.42.
About Spectral Medical
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Featured Articles
- Five stocks we like better than Spectral Medical
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Energy Transfer: Powering Data With Dividends and Diversification
- 3 Small Caps With Big Return Potential
- Qualcomm Stock Is Coiling for a Breakout
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.
